BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control, and repair peripheral nerves.
BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control and repair peripheral nerves.BioCircuit’s products provide clinicians with a practical ability to diagnose health conditions earlier, track the progression of symptoms over time, and select treatments more precisely for individual patients.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 4, 2021 | Grant | $1.70M | 1 | National Institutes of Health | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |